Nazende Gunday-Tureli
Overview
Explore the profile of Nazende Gunday-Tureli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
99
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Punz B, Brajnik M, Dokler J, Amos J, Johnson L, Reilly K, et al.
Beilstein J Nanotechnol
. 2025 Jan;
16:57-77.
PMID: 39877837
Nanosafety assessment, which seeks to evaluate the risks from exposure to nanoscale materials, spans materials synthesis and characterisation, exposure science, toxicology, and computational approaches, resulting in complex experimental workflows and...
2.
Akpinar Adscheid S, Rojas-Rodriguez M, Abdel-Hafez S, Pavone F, Schneider M, Tureli A, et al.
Pharmaceutics
. 2025 Jan;
17(1).
PMID: 39861735
: Drug delivery systems (DDSs) offer efficient treatment solutions to challenging diseases such as central nervous system (CNS) diseases by bypassing biological barriers such as the blood-brain barrier (BBB). Among...
3.
Akpinar Adscheid S, Tureli A, Gunday-Tureli N, Schneider M
Beilstein J Nanotechnol
. 2024 Nov;
15:1400-1414.
PMID: 39559726
Central nervous system diseases negatively affect patients and society. Providing successful noninvasive treatments for these diseases is challenging because of the presence of the blood-brain barrier. While protecting the brain's...
4.
Caputo F, Favre G, Borchard G, Calzolai L, Fisicaro P, Frejafon E, et al.
Drug Deliv Transl Res
. 2024 Jun;
14(9):2578-2588.
PMID: 38865038
The French National Metrology Institute (LNE) initiated a series of events to identify priorities for test methods and their harmonisation that directly address regulatory needs in Nanomedicine. One of these...
5.
Anand S, Fusco A, Gunday C, Gunday-Tureli N, Donnarumma G, Danti S, et al.
Bioact Mater
. 2024 May;
38:109-123.
PMID: 38699239
Approximately 740 million symptomatic patients are affected by otitis media every year. Being an inflammatory disease affecting the middle ear, it is one of the primary causes of tympanic membrane...
6.
Drinkovic N, Beus M, Barbir R, Debeljak Z, Tariba Lovakovic B, Kalcec N, et al.
Nanoscale
. 2024 Apr;
16(19):9412-9425.
PMID: 38650478
Nanotechnology has the potential to provide formulations of antitumor agents with increased selectivity towards cancer tissue thereby decreasing systemic toxicity. This study evaluated the potential of novel nanoformulation based on...
7.
Azimi B, Ricci C, Macchi T, Gunday C, Munafo S, Maleki H, et al.
Polymers (Basel)
. 2023 Sep;
15(17).
PMID: 37688120
The delivery of drugs through the skin barrier at a predetermined rate is the aim of transdermal drug delivery systems (TDDSs). However, so far, TDDS has not fully attained its...
8.
Oberlander J, Ayerbe R, Cabellos J, da Costa Marques R, Li B, Gunday-Tureli N, et al.
Cells
. 2022 Aug;
11(15).
PMID: 35954168
Cell therapy is an important new method in medicine and is being used for the treatment of an increasing number of diseases. The challenge here is the precise tracking of...
9.
Debeljak Z, Vrcek I, Drinkovic N, Micek V, Galic E, Gorup D, et al.
Analyst
. 2022 Jun;
147(14):3201-3208.
PMID: 35699493
Administration of cytotoxic agents like doxorubicin (DOX) is restrained by the effects on different non-targeted/non-cancerous tissues, which instigates the development of nano-enabled drug delivery systems, among others. In this study,...
10.
Interaction of surfactant coated PLGA nanoparticles with in vitro human brain-like endothelial cells
Moya E, Lombardo S, Vandenhaute E, Schneider M, Mysiorek C, Tureli A, et al.
Int J Pharm
. 2022 May;
621:121780.
PMID: 35504427
Treatment for CNS related diseases are limited by the difficulty of the drugs to cross the blood-brain barrier (BBB). The functionalization of polymeric nanoparticles (NPs) coated with the surfactants polysorbate...